Paeds Cases · genetics-dysmorphology-and-metabolism
Communicating a new congenital hyperinsulinism diagnosis — OSCE
OSCE communication and shared decision-making station: explaining to parents what a new congenital hyperinsulinism diagnosis means for their neonate who presented with hypoglycaemic seizures, why the hypoglycaemia was so dangerous, what the diazoxide and surgical options involve, the difference between focal and diffuse disease, and the recurrence risk for future pregnancies — while addressing guilt, the fear of surgery, and the search for a cure.
On this page & tools
Target exams
Task
Counsel the parents. You have five minutes. Demonstrate an organised, empathic, and accurate explanation that addresses the four questions a fellowship communication station rewards: why the hypoglycaemia was so dangerous and what happened to their daughter, what the immediate and longer-term plan is, what the diffuse-versus-focal distinction means for treatment, and what the recurrence risk and family implications are. The management and counselling framework follows the Pediatric Endocrine Society guidelines. [1]
What the family needs to hear
Open by acknowledging the fear and naming the guilt directly. They feel they did something wrong — name this and dissolve it: congenital hyperinsulinism is an inherited gene change that has often been carried silently in families for generations, and no one caused or chose it. Explain in plain language what happened: their daughter's pancreas was making too much insulin, the hormone that lowers blood sugar, even when her sugar was already low, so her brain was starved of its fuel. Reassure them that the team acted on it quickly, because the speed of correcting the hypoglycaemia is the single most important thing for her future development. [1] [12]
Address the danger honestly but without brutality. The low blood sugar was a genuine emergency because a starved brain can be permanently injured, and that is exactly why the team moved so fast to give her glucose and ran the blood tests the moment she was low. Be truthful that the seizure and the low glucose carry some risk to her long-term development, while affirming that the right thing was done and that her progress will be watched and supported closely. Promise honesty at every step, and follow through. [12]
The plan for their daughter, and the honest truth about cure
Lay out the plan concretely. Right now she is receiving glucose through a drip to keep her blood sugar safe while the team works out the best long-term treatment. The first medicine tried was diazoxide, which tells the pancreas to stop making insulin — and because she has not yet responded, the team is looking at other medicines such as sirolimus that work in a different way. Critically, the next step depends on the genetic result, which will tell the team whether her condition is in one small area of the pancreas (focal) or throughout the whole pancreas (diffuse). [1] [2]
Be explicit and honest about surgery and cure. There is no medicine that reverses the gene change, and no diet that fixes it. What changes her trajectory is keeping her blood sugar safe. If the genetic result shows a focal area, surgery to remove just that area can be curative — the rest of the pancreas is healthy. If it shows diffuse disease, the team uses medicines first, and only if those cannot keep her safe is a much larger operation considered, which has real consequences for her future including the risk of diabetes. Gently steer them away from unsupported online gene cures by naming that the desire for one is completely understandable, and by offering a trusted source and a follow-up with the metabolic and endocrine team. [2]
The family implications and future pregnancies
Explain the inheritance with care. Most forms of congenital hyperinsulinism are autosomal recessive, meaning both parents are healthy carriers and each future pregnancy carries a one-in-four chance of being affected — this is not anyone's fault, and carrier testing can be offered. Some forms are dominant or focal, which change the recurrence risk, and the genetic counsellor will explain exactly what the result means for them and for any siblings. Offer the options clearly — prenatal diagnosis during a future pregnancy, or preimplantation genetic testing with IVF to select an unaffected embryo — and connect them with the genetics service to explore these in their own time. The plan is shared across the metabolic and endocrine service, the genetics service, and their general practitioner, and a written emergency plan travels with their daughter everywhere. [1] [2]
References
- [1]Thornton PS, Stanley CA, De Leon DD, et al. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr, 2015.PMID 25957977
- [2]Kapoor RR, Flanagan SE, Arya VB, et al. Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. Eur J Endocrinol, 2013.PMID 23345197
- [12]Garg M, Devaskar SU. Exploring the long-term impacts of neonatal hypoglycemia to determine a safe threshold for glucose concentrations. Eur J Pediatr, 2025.PMID 40119223